Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Cash Flow Quality Index
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow Quality Index of 0.11x as of September 2025. Operating cash flow of CN¥112.12 Million is below net income of CN¥978.96 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Jilin Aodong Pharmaceutical Group Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Jilin Aodong Pharmaceutical Group Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Jilin Aodong Pharmaceutical Group Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Jilin Aodong Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see 000623 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | CN¥272.26 Million | CN¥2.40 Billion | ▲ +190.3% |
| 2024 | 0.04x | CN¥59.48 Million | CN¥1.52 Billion | ▼ -16.0% |
| 2023 | 0.05x | CN¥68.06 Million | CN¥1.46 Billion | ▼ -80.4% |
| 2022 | 0.24x | CN¥423.86 Million | CN¥1.78 Billion | ▲ +30.5% |
| 2021 | 0.18x | CN¥324.85 Million | CN¥1.78 Billion | ▼ -20.1% |
| 2020 | 0.23x | CN¥390.41 Million | CN¥1.71 Billion | ▼ -16.1% |
| 2019 | 0.27x | CN¥379.46 Million | CN¥1.39 Billion | ▼ -26.7% |
| 2018 | 0.37x | CN¥347.64 Million | CN¥935.19 Million | ▲ +167.4% |
| 2017 | 0.14x | CN¥256.49 Million | CN¥1.85 Billion | ▼ -30.6% |
| 2016 | 0.20x | CN¥333.81 Million | CN¥1.67 Billion | ▲ +34.3% |
| 2015 | 0.15x | CN¥388.03 Million | CN¥2.60 Billion | ▼ -26.8% |
| 2014 | 0.20x | CN¥288.83 Million | CN¥1.42 Billion | ▲ +7.5% |
| 2013 | 0.19x | CN¥201.22 Million | CN¥1.06 Billion | ▼ -54.8% |
| 2012 | 0.42x | CN¥272.40 Million | CN¥649.87 Million | ▲ +667.5% |
| 2011 | 0.05x | CN¥108.30 Million | CN¥1.98 Billion | ▼ -60.6% |
| 2010 | 0.14x | CN¥174.22 Million | CN¥1.26 Billion | ▼ -9.7% |
| 2009 | 0.15x | CN¥213.03 Million | CN¥1.39 Billion | ▼ -42.0% |
| 2008 | 0.27x | CN¥235.03 Million | CN¥886.21 Million | ▲ +38.0% |
| 2007 | 0.19x | CN¥384.69 Million | CN¥2.00 Billion | ▼ -59.2% |
| 2006 | 0.47x | CN¥187.99 Million | CN¥399.47 Million | ▼ -53.8% |
| 2005 | 1.02x | CN¥136.26 Million | CN¥133.76 Million | ▼ -27.7% |
| 2004 | 1.41x | CN¥218.53 Million | CN¥155.11 Million | ▲ +15.1% |
| 2003 | 1.22x | CN¥147.65 Million | CN¥120.67 Million | ▲ +2472.1% |
| 2002 | -0.05x | CN¥-4.58 Million | CN¥88.71 Million | ▼ -103.1% |
| 2001 | 1.69x | CN¥138.76 Million | CN¥82.07 Million | ▲ +91.8% |
| 2000 | 0.88x | CN¥77.04 Million | CN¥87.40 Million | ▼ -19.7% |
| 1999 | 1.10x | CN¥110.18 Million | CN¥100.32 Million | ▲ +419.3% |
| 1998 | -0.34x | CN¥-30.90 Million | CN¥89.82 Million | — |